Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 51, Issue 10, Pages 1283-1300
Publisher
Springer Nature
Online
2016-06-06
DOI
10.1038/bmt.2016.141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014
- (2015) Frederick R. Appelbaum et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reevaluation of the Pretransplant Assessment of Mortality Score after Allogeneic Hematopoietic Transplantation
- (2015) Brandon K.C. Au et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of Pretransplantation 18F-fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma
- (2015) Veronika Bachanova et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation
- (2015) Jennifer E. Vaughn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study
- (2015) Mohamed L. Sorror et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation
- (2015) Mahmoud ElSawy et al. BRITISH JOURNAL OF HAEMATOLOGY
- Validating the Allogeneic Stem Cell Transplantation Disease Risk Index
- (2015) Andrew B.M. Lim et al. TRANSPLANTATION
- Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplantation Outcomes? A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy
- (2014) Aya Nakaya et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- “To Combine or Not to Combine:” Optimizing Risk Assessment before Allogeneic Hematopoietic Cell Transplantation
- (2014) Mahmoud ElSawy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Validation of the Disease Risk Index for Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation after T Cell Depletion
- (2014) Yan Beauverd et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality
- (2014) M. L. Sorror et al. BLOOD
- Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
- (2014) P. Armand et al. BLOOD
- EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation
- (2014) H-t Wang et al. BONE MARROW TRANSPLANTATION
- Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients
- (2014) L. S. Muffly et al. HAEMATOLOGICA
- Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation
- (2014) Mohamed L. Sorror et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of physical function tests: hand grip strength and six-minute walking test in elderly hospitalized patients
- (2014) Esther Martín-Ponce et al. Scientific Reports
- The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation
- (2013) Xiao-Dong Mo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Hand Grip Strength and 2-Minute Walk Test in Chronic Graft-versus-Host Disease Assessment: Analysis from the Chronic GVHD Consortium
- (2013) Joseph Pidala et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
- (2013) Mohamed L. Sorror et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- How I assess comorbidities before hematopoietic cell transplantation
- (2013) M. L. Sorror BLOOD
- Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS
- (2013) M Robin et al. BONE MARROW TRANSPLANTATION
- First application of the EBMT risk score in double umbilical cord blood transplantation for hematologic malignancies: Significant impact on different outcomes
- (2013) Hélène Labussière Wallet et al. EXPERIMENTAL HEMATOLOGY
- Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors
- (2013) S. Servais et al. HAEMATOLOGICA
- Hematopoietic Cell Transplantation–Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to the Intensive Care Unit
- (2013) Ulas D. Bayraktar et al. JOURNAL OF CLINICAL ONCOLOGY
- The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation
- (2013) Shahrukh Hashmi et al. LEUKEMIA RESEARCH
- Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study
- (2012) R. Raimondi et al. BLOOD
- Discovery and validation of graft-versus-host disease biomarkers
- (2012) S. Paczesny BLOOD
- A disease risk index for patients undergoing allogeneic stem cell transplantation
- (2012) P. Armand et al. BLOOD
- Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity
- (2012) A Shimoni et al. BONE MARROW TRANSPLANTATION
- MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation
- (2012) E. W. Petersdorf et al. Science Translational Medicine
- The Hematopoietic Cell Transplantation-Specific Comorbidity Index Fails to Predict Outcomes in High-Risk AML Patients Undergoing Allogeneic Transplantation—Investigation of Potential Limitations of the Index
- (2011) Nicole Birninger et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research Study
- (2011) Philippe Armand et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure
- (2011) Katayoun Rezvani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients
- (2011) A. R. Smith et al. BLOOD
- Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system
- (2011) T. Luft et al. BLOOD
- Validation of pretransplantation assessment of mortality risk score in the outcome of hematopoietic SCT in non-Caucasians
- (2011) Y Mori et al. BONE MARROW TRANSPLANTATION
- Immunohistochemistry of affected tissue may guide cGVHD treatment decisions
- (2011) K M Williams et al. BONE MARROW TRANSPLANTATION
- Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation
- (2011) S W Bokhari et al. BONE MARROW TRANSPLANTATION
- The EBMT risk score
- (2011) A Gratwohl BONE MARROW TRANSPLANTATION
- Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia
- (2011) Gunnar Juliusson et al. CANCER
- Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
- (2011) Mohamed L. Sorror et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gait Speed and Survival in Older Adults
- (2011) Stephanie Studenski JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Review of Stem-Cell Transplantation for Myelodysplastic Syndromes in Older Patients in the Context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome Emanating From the Centers for Medicare and Medicaid Services
- (2011) Sergio A. Giralt et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia
- (2011) T Lodewyck et al. LEUKEMIA
- Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase
- (2010) J. Pavlu et al. BLOOD
- Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights
- (2010) M L Sorror et al. BONE MARROW TRANSPLANTATION
- Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT
- (2010) L Castagna et al. BONE MARROW TRANSPLANTATION
- Prognostic Significance of Expression of a Single MicroRNA,miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2010) Sebastian Schwind et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC
- (2009) Pere Barba et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML
- (2009) Z Y Lim et al. BONE MARROW TRANSPLANTATION
- Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromes
- (2009) P Armand et al. BONE MARROW TRANSPLANTATION
- A modified comorbidity index for hematopoietic cell transplantation
- (2009) T E DeFor et al. BONE MARROW TRANSPLANTATION
- Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study
- (2009) K Kataoka et al. BONE MARROW TRANSPLANTATION
- Risk score for outcome after allogeneic hematopoietic stem cell transplantation
- (2009) Alois Gratwohl et al. CANCER
- A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia
- (2009) T. H. Terwey et al. HAEMATOLOGICA
- The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
- (2009) L Farina et al. LEUKEMIA
- Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome
- (2008) Philippe Armand et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Does the Hematopoietic Cell Transplantation Specific Comorbidity Index Predict Transplant Outcomes? A Validation Study in a Large Cohort of Umbilical Cord Blood and Matched Related Donor Transplants
- (2008) Navneet S. Majhail et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pretreatment C-Reactive Protein Is a Predictor for Outcomes after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation
- (2008) Andrew S. Artz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
- (2008) I. F. Khouri et al. BLOOD
- Performance status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), predicts mortality at a Canadian transplant center
- (2008) R Guilfoyle et al. BONE MARROW TRANSPLANTATION
- Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
- (2008) Mohamed Sorror et al. CANCER
- Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning
- (2008) Mohamed L. Sorror et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of comorbidity indexes on non-relapse mortality
- (2008) A Xhaard et al. LEUKEMIA
- Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation
- (2008) Pierre-Yves Bochud et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More